| ISIN | LU1681197635 |
|---|---|
| Valor Number | 38235019 |
| Bloomberg Global ID | |
| Fund Name | Swiss Life Funds (LUX) Equity Global High Dividend EUR AM Cap |
| Fund Provider |
Swiss Life Asset Management AG
Zürich, Switzerland Phone: +41 44 284 77 09 E-Mail: info@swisslife-am.com Web: www.swisslife-am.com |
| Fund Provider | Swiss Life Asset Management AG |
| Representative in Switzerland |
Swiss Life Asset Management AG Zürich Phone: +41 43 284 33 11 |
| Distributor(s) |
Swiss Life Asset Management AG Zürich Phone: +41 43 284 33 11 |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Luxembourg |
| Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
| Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
| Investment Strategy *** | The objective of this Sub-Fund is to achieve a high long term capital growth by investing in and/or being exposed to a globally diversified equity portfolio of companies with above-average yearly dividend payments through direct or indirect investments via other UCITS and/or UCIs. |
| Peculiarities |
| Current Price * | 17,921.76 EUR | 30.10.2025 |
|---|---|---|
| Previous Price * | 17,819.82 EUR | 29.10.2025 |
| 52 Week High * | 18,541.68 EUR | 28.02.2025 |
| 52 Week Low * | 16,154.18 EUR | 08.04.2025 |
| NAV * | 17,921.76 EUR | 30.10.2025 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 182,367,205 | |
| Unit/Share Assets *** | 12,219,754 | |
| Trading Information SIX | ||
| YTD Performance | +2.59% |
31.12.2024 - 30.10.2025
31.12.2024 30.10.2025 |
|---|---|---|
| YTD Performance (in CHF) | +1.22% |
31.12.2024 - 30.10.2025
31.12.2024 30.10.2025 |
| 1 month | +1.20% |
30.09.2025 - 30.10.2025
30.09.2025 30.10.2025 |
| 3 months | +2.53% |
30.07.2025 - 30.10.2025
30.07.2025 30.10.2025 |
| 6 months | +5.90% |
30.04.2025 - 30.10.2025
30.04.2025 30.10.2025 |
| 1 year | +5.17% |
30.10.2024 - 30.10.2025
30.10.2024 30.10.2025 |
| 2 years | +31.03% |
30.10.2023 - 30.10.2025
30.10.2023 30.10.2025 |
| 3 years | +26.99% |
31.10.2022 - 30.10.2025
31.10.2022 30.10.2025 |
| 5 years | +81.23% |
30.10.2020 - 30.10.2025
30.10.2020 30.10.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Johnson & Johnson | 3.37% | |
|---|---|---|
| The Home Depot Inc | 2.99% | |
| AbbVie Inc | 2.84% | |
| Procter & Gamble Co | 2.67% | |
| Exxon Mobil Corp | 1.93% | |
| Merck & Co Inc | 1.87% | |
| Novartis AG Registered Shares | 1.74% | |
| Coca-Cola Co | 1.71% | |
| Verizon Communications Inc | 1.64% | |
| Pfizer Inc | 1.43% | |
| Last data update | 30.09.2025 | |
| TER *** | 0.30% |
|---|---|
| TER date *** | 28.02.2025 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 1.50% |
| Ongoing Charges *** | 0.31% |
|
SRRI ***
|
|
| SRRI date *** | 30.09.2025 |